Loading...

Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly

Stroke is a major cause of both death and disability. However, there are no pharmacological treatments used in most countries other than recombinant tissue plasminogen activator, a thrombolytic, and this is only used in about 4% of patients presenting after an acute ischaemic stroke. One novel throm...

Full description

Saved in:
Bibliographic Details
Main Author: Green, A R
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2008
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2268079/
https://ncbi.nlm.nih.gov/pubmed/18059324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0707594
Tags: Add Tag
No Tags, Be the first to tag this record!